Abstract
Shared neurophysiology of addiction and sleep disorders results in a bidirectional interplay. Diagnosing and treating primary sleep disorders, particularly in adolescents, can prevent the development of addiction in susceptible individuals. Addressing sleep issues in early recovery, and throughout maintenance, can prevent relapse. Cannabis use for insomnia shows mixed results; assisting with onset sleep latency in early use, this subsides with chronic use and holds addiction risk. Insomnia is a primary complaint of cannabis withdrawal syndrome and a primary cause of relapse in cannabis use disorder. An ideal sleep aid would prevent relapse and have low abuse potential. Pharmaceutical and behavioral options include suvorexant, mirtazapine, trazodone, and aerobic exercise, but clinical trials are lacking to demonstrate efficacy.
Original language | English (US) |
---|---|
Pages (from-to) | 163-171 |
Number of pages | 9 |
Journal | Advances in experimental medicine and biology |
Volume | 1297 |
DOIs | |
State | Published - 2021 |
Keywords
- Addiction
- Cannabis
- Insomnia
- Orexin
- Relapse
- Sleep disorders
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology